SSB
EDIT icon

Sandy Spring Bank’s Editas Medicine EDIT Stock Holding History

Sandy Spring Bank’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$3 Buy
+2
New +$3 ﹤0.01% 1216
2024
Q4 		– Sell
-252
Closed -$860 – 1250
2024
Q3 		$860 Buy
252
+100
+66% +$435 ﹤0.01% 1100
2024
Q2 		$710 Buy
152
+50
+49% +$282 ﹤0.01% 1173
2024
Q1 		$757 Buy
102
+100
+5,000% +$831 ﹤0.01% 1134
2023
Q4 		$21 Hold
2
– – ﹤0.01% 1165
2023
Q3 		$16 Hold
2
– – ﹤0.01% 1177
2023
Q2 		$17 Hold
2
– – ﹤0.01% 1217
2023
Q1 		$15 Hold
2
– – ﹤0.01% 1154
2022
Q4 		$18 Buy
+2
New +$22 ﹤0.01% 1135

Other funds holding EDIT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Sandy Spring Bank's EDIT Position: Q1 2025 in Review

Sandy Spring Bank opened a new position in Editas Medicine (EDIT) in Q1 2025: 2 shares worth $3. The stake represents ﹤0.01% of the portfolio and ranks #1216 among its holdings. This is a return to the name: Sandy Spring Bank previously reported a position in EDIT as recently as Q3 2024.

Sandy Spring Bank first reported a position in EDIT in Q4 2022 and has held it in 9 quarters since. The position peaked at $860 in Q3 2024. 195 funds tracked by Wall St. Rank hold EDIT as of Q1 2025.

  • Sandy Spring Bank held 2 shares of Editas Medicine worth $3 as of Q1 2025.
  • Editas Medicine was a new Sandy Spring Bank position in Q1 2025.
  • Editas Medicine made up ﹤0.01% of Sandy Spring Bank's portfolio in Q1 2025, its #1216 holding.
  • Sandy Spring Bank first reported a position in Editas Medicine in Q4 2022 and has held it in 9 quarters since.
  • Sandy Spring Bank's Editas Medicine position peaked at $860 in Q3 2024.
  • 195 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2025.

Based on Sandy Spring Bank's 13F filing for Q1 2025, filed 12 May 2025.